Stepan (NYSE:SCL – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday.
Stepan Price Performance
Shares of Stepan stock traded up $1.41 during trading on Thursday, reaching $63.94. The company’s stock had a trading volume of 113,269 shares, compared to its average volume of 124,893. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 0.29. Stepan has a 12-month low of $59.55 and a 12-month high of $94.76. The company has a market capitalization of $1.44 billion, a P/E ratio of 31.81 and a beta of 0.84. The business has a 50 day moving average price of $64.21 and a 200-day moving average price of $71.39.
Stepan (NYSE:SCL – Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The basic materials company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.33). The company had revenue of $525.60 million for the quarter, compared to analyst estimates of $520.97 million. Stepan had a net margin of 2.10% and a return on equity of 4.56%. Stepan’s revenue was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.33 earnings per share. As a group, sell-side analysts anticipate that Stepan will post 2.43 EPS for the current year.
Institutional Investors Weigh In On Stepan
Stepan Company Profile
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.
Featured Stories
- Five stocks we like better than Stepan
- Learn Technical Analysis Skills to Master the Stock Market
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Monster Growth Stocks to Buy Now
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The 3 Best Blue-Chip Stocks to Buy Now
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.